DEFA14A: Quest Diagnostics Sets Date for 2025 Annual Stockholders Meeting

Quest Diagnostics will hold its annual stockholders meeting on May 15, 2025, to vote on director elections, executive compensation, auditor ratification, and a stockholder proposal.

Summary

• Quest Diagnostics Incorporated will hold its 2025 Annual Meeting of Stockholders on May 15, 2025, at 10:30 a.m. local time in Clifton, New Jersey.
• Stockholders will vote on the election of ten director nominees.
• An advisory resolution to approve executive officer compensation will be voted on.
• The ratification of the appointment of the independent registered public accounting firm for 2025 will be voted on.
• A stockholder proposal will be considered, if properly presented.
• The Board of Directors recommends voting FOR the election of the ten directors.
• The Board of Directors recommends voting FOR the advisory resolution on executive compensation.
• The Board of Directors recommends voting FOR the ratification of the accounting firm appointment.
• The Board of Directors recommends voting AGAINST the stockholder proposal.
• Proxy materials, including the 2025 Proxy Statement and the 2024 Annual Report, are available online at www.ViewMaterial.com/DGX.
• Stockholders can request a paper or e-mail copy of the proxy materials free of charge by May 1, 2025.
• Voting can be done online until 11:59 p.m. (EDT) on May 14, 2025, or in person at the Annual Meeting.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an upcoming shareholder meeting, with a neutral to slightly positive sentiment due to the clear communication and board recommendations.

Positives

• Stockholders have multiple avenues to access proxy materials and cast their votes, including online access, paper copies, and in-person voting.
• The Board of Directors provides clear recommendations on how to vote on each proposal.

Future Outlook

The document outlines the agenda and recommendations for the upcoming Annual Meeting of Stockholders, focusing on governance and operational matters for the coming year.

Management Comments

• The Quest Diagnostics Board of Directors recommends you vote FOR the election of the ten directors, FOR the advisory resolution to approve the executive officer compensation disclosed in the Company's 2025 proxy statement, FOR ratification of the appointment of our independent registered public accounting firm for 2025 and AGAINST the stockholder proposal, as described in the accompanying proxy statement, if properly presented at the Annual Meeting.

Industry Context

This announcement is a standard corporate governance procedure for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions.

Stakeholder Impact

• Shareholders are directly impacted through their voting rights on key company decisions.
• Employees are indirectly impacted through decisions on executive compensation and company direction.

Next Steps

• Stockholders should review the proxy materials.
• Stockholders should cast their votes before the deadlines.
• Attend the Annual Meeting of Stockholders on May 15, 2025, if desired.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Quest Diagnostics, Voting, Directors, Executive Compensation, Auditor, Proposal